Phoenix, Arizona-based Healthcare Outcomes Performance Company (HOPCo) has acquired Stryker Performance Solutions, LLC.’s (SPS) value-based care business.
HOPCo Acquires Stryker Performance Solutions Platform
1 min read Premium comments
Secondary#hopco#healthcareoutcomesperformancecompany#strykerperformancesolutions
HOPCo acquired SPS’ “BPCI-A [bundled payments for care improvement advanced] value-based care convener business and segments of SPS’ health system orthopedic service line analytics subscription business.” Several SPS employees will be joining HOPCo to ensure existing customers continue to receive service.
The transaction includes SPS’ Episode Performance Manager™, SPS’ outcomes management software. Stakeholders use the web-based dashboard to analyze Medicare claims data.
The transaction also includes the licensing of RecoveryCoach™ and the orthopedic Hospital Reported Outcomes. The new RecoveryCoach platform is an “online care coordination and patient engagement portal.” Hospital Reported Outcomes is an analytics tool that includes a web-based dashboard to track and report outcomes.
HOPCo provides “practice and outcomes management, value-based health care solutions and care coordination for musculoskeletal practices, health systems and clinically integrated care networks.” With the acquisition, HOPCo grows its musculoskeletal bundle payment programs and becomes the nation’s largest orthopedic service lines manager.
HOPCo Chairman and CEO David Jacofsky, M.D. told OTW, “The SPS platform was a natural complement to HOPCo’s existing suite of tools and our risk-based and population health contracting models. For the last decade, HOPCo has been leading the transition to value-based care in the musculoskeletal space using our medical economics and claims analytics, proprietary data and IT platforms, and clinical decision support tools.”
Dr. Jacofsky continued, “The acquisition of the SPS platform will further enhance our capabilities to transform the markets for practices, payors and health systems by identifying areas for outcomes improvement, operational optimization, and implementation of these changes in a meaningful way that aligns market stakeholders. We are excited about the opportunity to offer these additional capabilities to HOPCo’s previously existing and newly acquired clients and partners.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.